The Artificial Intelligence in the Cancer Market research report provides extensive market coverage that includes qualitative and quantitative analysis of the overall market, its segments, and regional analysis. It sheds light on market growth drivers to understand the business’s financial and operational output to improvise the company’s performance and strategies. Furthermore, the report also incorporates challenges and opportunities that enable stakeholders to develop a strategic and precise business plan.
Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5703701
Global Artificial Intelligence in Cancer Market: Key Players
Butterfly Network, Inc.
Zebra Medical Vision
For years, artificial intelligence (AI) has caught society’s interest and generated excitement about its potential t–enhance our lives. AI is already a part of our everyday lives, as well as our interactions with media, transportation, and communications. AI applications in healthcare are gaining traction as a way t–enhance illness diagnosis, management, and the creation of successful treatments. Given the enormous number of patients diagnosed with cancer and the large quantity of data collected during treatment, AI applications t–improve oncologic care are of particular interest. During medical operations, artificial intelligence assists medical practitioners in retrieving information, interpreting pictures, and planning therapy. It als–makes healthcare workers’ jobs easier.
Global Artificial Intelligence in Cancer market is expected t–project a notable CAGR of XX.X% in 2030
Global Artificial Intelligence in Cancer t–surpass USD XXXX billion by 2030 from USD XXXX billion in 2020 at a CAGR of XX.X% in the coming years, i.e., 2021-30. Some of the main variables helping revenue growth in the market include an increase in the inflow of patient health-related digital data, growing need t–minimize healthcare cost, and rising desire for tailored medication. Another important reason that has increased the need t–study and identify illnesses in their early stages is the rise in the prevalence of chronic diseases such as cancer. Deep learning technology would make it simple t–anticipate illnesses based on past health data. Furthermore, content analytics, Natural Language Processing (NLP) technologies, and Artificial Intelligence (AI) can aid in the patient’s rapid diagnosis.
Recent highlights in the Global Artificial Intelligence in Cancer Market
In August 2020, Digital Diagnostics Inc., formerly known as IDx, purchased 3Derm Systems Inc. The acquisition intended t–expand 3DermTriage’s dermatological telemedicine capabilities and prepare its autonomous AI skin cancer diagnosis device, 3DermSpot, for FDA approval.
In September 2019, For creating applications for its Edison AI platform, GE Healthcare signed a Cooperation agreement with five local Chinese software development companies-12Sigma Technologies, Shukun Technology, Biomind, YITU Technology, and Yizhun Medical AI. These important partners are expected t–deliver mature software products that would enable GE Healthcare’s digital transition t–g–smoothly.
Global Artificial Intelligence in Cancer Market: Segments
Targeted Therapy segment t–grow with the highest CAGR during 2020-30
Global Artificial Intelligence in Cancer market is segmented by Product Type int–Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Phototherapy, Targeted therapy, Gene Therapy, Sonodynamic Therapy. Among these Targeted Therapy is expected t–have the highest growth in the forecast period. This can be attributed t–the discovery of cancer cells’ molecular targets. Recent developments in cellular technology and gene therapy have improved our understanding of tumor cells and their metabolism at the molecular level, prompting the development of tailored cancer medication treatments.
Lung cancer segment t–grow with the highest CAGR during 2020-30
Global Artificial Intelligence in Cancer market is segmented by Cancer Type int–Lung, Breast, Melanoma, Colorectal, Prostate and others. The high prevalence of breast cancer across the world is a key contributor t–this segment’s substantial share. However, the lung cancer category is anticipated t–grow the most throughout the projection period. The rising prevalence of lung cancer throughout the world, as well as the growing demand for early detection, are driving this segment’s rise.
Expansion of companies
T–help end-users overcome the shortage of radiologists, deliver value-based care, early disease detection and diagnosis, and maintain a competitive edge in the market, companies are increasingly focusing on expanding their geographical reach and introducing newer, innovative solutions through various strategies, including partnerships, product launches, and collaborations.
Medical professionals’ reluctance t–use AI-based technology
Due t–the rapid rise of digital health, healthcare practitioners may now aid patients with innovative treatment techniques. AI technologies provide doctors with tools t–help them diagnose and treat patients more efficiently. Doctors, on the other hand, have shown a reluctance t–adopt new technology. For example, there is a widespread belief among medical professionals that AI will eventually replace physicians. Doctors and radiologists feel that qualities like empathy and persuasion are human abilities, and that technological advancements cannot totally eliminate the need for a doctor. Furthermore, there is fear that patients may become overly reliant on these technologies and will foreg–important in-person treatments, thereby jeopardizing long-term doctor-patient relationships.
Global Artificial Intelligence in Cancer Market: Regions
Global Artificial Intelligence in Cancer market is segmented based on regional analysis int–five major regions. These include North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Global AI in Cancer in North America held the largest market share in the year 2020. However, The APAC market is expected t–grow at the fastest rate over the forecast period, owing t–emerging market growth strategies, improved medical diagnostic infrastructure, an ageing population, rising cancer prevalence, favorable government initiatives for AI in healthcare, and an increase in the number of COVID-19 positive patients.
Global Artificial Intelligence in Cancer Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR United Kingdom, France, Germany and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR China, Japan, Australia and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR North Africa, Israel, GCC, South Africa and Rest of MENA
Global Artificial Intelligence in Cancer Market report als–contains analysis on:
Artificial Intelligence in Cancer Segments:
By Cancer Type
By End User
Artificial Intelligence in Cancer Market Dynamics
Artificial Intelligence in Cancer Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Direct Purchase of Artificial Intelligence in the Cancer Market Research Report at: https://www.reportsnreports.com/purchase.aspx?name=5703701
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Hadapsar, Pune-411013, India
+ 1 888 391 5441